✦ LIBER ✦

Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis

✍ Scribed by H. Taggart; J. Cheng; P. Archbold

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 54 KB
Volume: 21
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-009-1088-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of intravenous zoledronic ac

The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis

✍ Jawl-Shan Hwang; Lin-Show Chin; Jung-Fu Chen; Tzay-Shing Yang; Po-Quang Chen; Ke 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 228 KB

Bone material properties in actively bon

Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid

✍ Sonja Gamsjaeger; Birgit Buchinger; Elizabeth Zwettler; Robert Recker; Dennis Bl 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 473 KB

Zoledronic acid (ZOL), a third-generation aminobisphosphonate, showed pronounced antifracture efficacy in a phase III clinical trial [Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly-Pivotal Fracture Trial (HORIZON-PFT)] when administered yearly (5-mg infusions of ZOL), produci

Post hoc analysis of a single IV infusio

Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis

✍ C. Roux; D. M. Reid; J.-P. Devogelaer; K. Saag; C. S. Lau; J.-Y. Reginster; P. P 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 171 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma : A randomized, double-blind, multicenter, comparative trial

✍ Lee S. Rosen; David Gordon; Mary Kaminski; Anthony Howell; Andrew Belch; John Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## BACKGROUND The goal of the current study was to compare the long‐term (25‐month) safety and efficacy of zoledronic acid with pamidronate in patients with bone lesions secondary to advanced breast carcinoma or multiple myeloma. ## METHODS Patients (__n__ = 1648) were randomized to